Search and Filter
Results per Page:
How Fred Hutch scientists tackle world’s top infectious killer, TB
Expertise in immunology and biostatistics underpin foundational work in tuberculosis vaccines, biomarkers and pathology that could usher in a new era
The benefits of HIV research? Let us count the ways
HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts
Viral immunologist taps ‘incredible potential’ of immune system
Dr. Paul Thomas will combine computational and empirical approaches to understand the immune repertoire and turn this knowledge into new diagnostic and therapeutic tools
When donors go all in, the magic begins
Aldarra Foundation achieved maximum impact at Fred Hutch and beyond by giving boldly, with purpose and on a timeline
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Dr. Peter Gilbert receives Marvin Zelen Leadership Award in Statistical Science
Award recognizes leadership in HIV vaccine trial development, analysis
‘Action and progress link our globe’
HVTN’s Dr. Daniel Driffin focused on hope in remarks at White House World AIDS Day event
Laying the groundwork for a new cancer-preventive vaccine
Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma
Going straight to the source in defense against infant RSV
New anti-idiotype antibody a first step in possible strategy to build infant immunity during vulnerable window
Finding passion and community
Fred Hutch Postbaccalaureate Scholar Program bridges gap between college and graduate school for aspiring scientists
Vaccine trial volunteer works to empower her community, end HIV
Community Advisory Board member Tasia Baldwin helps raise awareness of the ongoing HIV epidemic and how individuals can get involved in research aimed at ending it
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
Virus researchers Cohn and Blanco-Melo win coveted grants
Pew and Searle scholar programs each give a boost to accomplished, early-career scientists
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Early research may show new way to block dengue and Zika virus
Scientists find different flavor of broadly neutralizing antibody that could lead to new vaccines for growing threat
Going long: Viruses linger with lasting impact
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should ‘long COVID’ surprise us?
Two rare antibodies, one drug, four viruses
Researchers discover antibodies to block RSV, other viruses that put transplant patients at risk
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Could a 100-year-old TB vaccine help scientists find a better one?
Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis
On World AIDS Day, a broad view of continuing work
Teams of Fred Hutch scientists test vaccines, treatments, new strategies